Jouni Tourunen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jouni Tourunen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Antti Weckroth
A-Clinic Foundation Järvenpää Addiction Hospital
1 shared publication - Hedda Giertsen
Institutt for kriminologi og rettssosiologi, Universitetet i Oslo, Postboks 6706, St. Olavs plass, NO-0130 Oslo
1 shared publication - Per Åke Nylander
Department of Law, Psychology and Social Work, Örebro University, Örebro, Sweden
1 shared publication Teemu Kaskela
Järvenpää Addiction Hospital, HAARAJOKI
1 shared publication- Teemu Kaskela
A-Clinic Foundation
1 shared publication - Torsten Kolind
Aarhus University
1 shared publication
Latest Publications
- Open Access
- 1 April 2015
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 32 (2) , 145-164
Prisoners' experiences of drug treatment and punishment in four Nordic countries
Aims: This article describes and analyses prisoners' experiences of drug treatment in prison in four Nordic countries: Denmark, Finland, Norway and Sweden. The article examines how prisoners experience drug treatment, control and sanctions as related to three main topics, namely motivation; the content of the measure and relations to staff; and control and sanctions. Methods & DATA: – The article is based on data from twelve prisons, three in each of the four countries; 91 interviews with prisoners; and around six months of observation. The two main kinds of drug treatment measures are drug treatment units and day programmes. Results: – Prisoners described several motives to participate in drug treatment measures: to leave drugs and crime; to renew relations with family and friends; to solve health problems; and to improve their prison conditions. Prisoners found that drug treatment measures offered possibilities to acquire new ways of being. Staff behaviour seemed to be more important to prisoners than the methods used, and some prisoners seemed more positive to staff involved with the drug treatment than to other staff. A surprising finding was the prisoners' limited critique of controls and sanctions. We see this as embedded in the situation of being a prisoner, and also in relation to contexts outside prison. Conclusion: In discussing their experiences in the treatment units, prisoners are not so concerned about the rehabilitative features or the controls and sanctions. They evaluate their present situation in light of a future, which is their real concern. This is in line with a main task for staff, which is to prepare prisoners for release.
- 1 April 2015
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 32 (2) , 145-164
Open AccessPrisoners' experiences of drug treatment and punishment in four Nordic countries
Aims: This article describes and analyses prisoners' experiences of drug treatment in prison in four Nordic countries: Denmark, Finland, Norway and Sweden. The article examines how prisoners experience drug treatment, control and sanctions as related to three main topics, namely motivation; the content of the measure and relations to staff; and control and sanctions. Methods & DATA: – The article is based on data from twelve prisons, three in each of the four countries; 91 interviews with prisoners; and around six months of observation. The two main kinds of drug treatment measures are drug treatment units and day programmes. Results: – Prisoners described several motives to participate in drug treatment measures: to leave drugs and crime; to renew relations with family and friends; to solve health problems; and to improve their prison conditions. Prisoners found that drug treatment measures offered possibilities to acquire new ways of being. Staff behaviour seemed to be more important to prisoners than the methods used, and some prisoners seemed more positive to staff involved with the drug treatment than to other staff. A surprising finding was the prisoners' limited critique of controls and sanctions. We see this as embedded in the situation of being a prisoner, and also in relation to contexts outside prison. Conclusion: In discussing their experiences in the treatment units, prisoners are not so concerned about the rehabilitative features or the controls and sanctions. They evaluate their present situation in light of a future, which is their real concern. This is in line with a main task for staff, which is to prepare prisoners for release.
- Open Access
- 1 January 2012
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 29 (6) , 575-588
Prison-based drug treatment in Finland: History, shifts in policy making and current status
Aim: The article outlines, at the level of political discourse, changes in drug and criminal policy that may have influenced the penal system as a backdrop to the rise of prison-based drug treatment programmes (PBDT) in Finland. Methods and Data: Our perspective is historical. The article is based on historical and political documents, scholarly research and white papers. Results: The history of PBDT in Finland is characterised by an absence of drug treatment programmes until the 1980s, first initiatives at the end of the 1980s, enthusiastic programme development from the mid-1990s, and decreasing interest during recent years. Unlike the National Drug Strategy, the Prison Drug Strategy aimed at a drug-free environment (zero tolerance) and implemented harm-reduction measures only to a limited extent. Conclusion: The development of PBDT represents the new way of performing treatment in prisons, with features of managerialism. PBDT is also affected by an organisational segregation of rehabilitation and medical treatment, which prevents integration of harm-reduction measures with rehabilitative treatment, and is in conflict with general aims of integrating substance abuse treatment to mental and healthcare services in Finland. In the spirit of a new kind of Penal Welfarism, the role of documented individual risk and needs assessment in defining an offender's sentence has increased.
- 1 January 2012
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 29 (6) , 575-588
Open AccessPrison-based drug treatment in Finland: History, shifts in policy making and current status
Aim: The article outlines, at the level of political discourse, changes in drug and criminal policy that may have influenced the penal system as a backdrop to the rise of prison-based drug treatment programmes (PBDT) in Finland. Methods and Data: Our perspective is historical. The article is based on historical and political documents, scholarly research and white papers. Results: The history of PBDT in Finland is characterised by an absence of drug treatment programmes until the 1980s, first initiatives at the end of the 1980s, enthusiastic programme development from the mid-1990s, and decreasing interest during recent years. Unlike the National Drug Strategy, the Prison Drug Strategy aimed at a drug-free environment (zero tolerance) and implemented harm-reduction measures only to a limited extent. Conclusion: The development of PBDT represents the new way of performing treatment in prisons, with features of managerialism. PBDT is also affected by an organisational segregation of rehabilitation and medical treatment, which prevents integration of harm-reduction measures with rehabilitative treatment, and is in conflict with general aims of integrating substance abuse treatment to mental and healthcare services in Finland. In the spirit of a new kind of Penal Welfarism, the role of documented individual risk and needs assessment in defining an offender's sentence has increased.
- Open Access
- 6 December 2010
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 10 (6)
From controlled opioid substitution treatment to pharmacy delivery of buprenorphine-naloxone and to treatment in primary health care: the views of patients and personnel
There are 4000–5000 opioid abusers and about 1700 patients in opioid substitution treatment in Finland. New legislation (2008) allows less restrictive treatment models than before. To assess advantages and disadvantages of pharmacy delivery of buprenorphine-naloxone and referral of stabile patients into primary health care. The setting was five Finnish outpatient clinics involved in treatment of opioid dependence in 2008–2009. Seventy-four patients (75% males, mean age 33, ½– 8 years in treatment) were interviewed. A questionnaire regarding the patients'´ situation was filled in by the nurses (n=166 patients). The view of personnel was studied in five group interviews (n=24) and through a questionnaire (n=36). Qualitative and quantitative methods were used. Most patients were unemployed, had psychiatric problems, and had heavy history of drug abuse. Transition to pharmacy delivery and to primary health care was more difficult and time-consuming than expected. This was due to patients' insistent personal need for psychosocial treatment or concerns of the personnel. Financial and organizational factors also played an important role. A variety of treatment models, careful evaluation of the patients’ situation, and training of personnel of clinics and health centres, and pharmacy staff is needed. Both patients and personnel were willing to move towards less restrictive models, if they were flexible enough.
- 6 December 2010
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 10 (6)
Open AccessFrom controlled opioid substitution treatment to pharmacy delivery of buprenorphine-naloxone and to treatment in primary health care: the views of patients and personnel
There are 4000–5000 opioid abusers and about 1700 patients in opioid substitution treatment in Finland. New legislation (2008) allows less restrictive treatment models than before. To assess advantages and disadvantages of pharmacy delivery of buprenorphine-naloxone and referral of stabile patients into primary health care. The setting was five Finnish outpatient clinics involved in treatment of opioid dependence in 2008–2009. Seventy-four patients (75% males, mean age 33, ½– 8 years in treatment) were interviewed. A questionnaire regarding the patients'´ situation was filled in by the nurses (n=166 patients). The view of personnel was studied in five group interviews (n=24) and through a questionnaire (n=36). Qualitative and quantitative methods were used. Most patients were unemployed, had psychiatric problems, and had heavy history of drug abuse. Transition to pharmacy delivery and to primary health care was more difficult and time-consuming than expected. This was due to patients' insistent personal need for psychosocial treatment or concerns of the personnel. Financial and organizational factors also played an important role. A variety of treatment models, careful evaluation of the patients’ situation, and training of personnel of clinics and health centres, and pharmacy staff is needed. Both patients and personnel were willing to move towards less restrictive models, if they were flexible enough.